{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:56:07Z","timestamp":1753887367232,"version":"3.41.2"},"reference-count":16,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Statin use can lead to various muscle-related issues, including benign creatine kinase (CK) elevations, myalgias, toxic myopathies, rhabdomyolysis, and immune-mediated necrotizing myositis (IMNM), which primarily affects older males. IMNM presents with proximal muscle weakness, elevated CK levels, and specific antibodies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case presentation<\/jats:title>\n                  <jats:p>We describe a 72-year-old patient with muscle weakness persisting for over 3 years after statin therapy. Initially suspected to have a genetic disorder, further testing revealed elevated anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) antibodies, indicating immune-mediated myopathy. Despite the absence of inflammatory changes on biopsy, the patient responded positively to immune therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This case highlights challenges in diagnosing immune-mediated myopathy, especially in older patients with atypical presentations. Testing for HMGCR antibodies can aid in diagnosis, particularly when inflammatory markers are absent. Awareness of red flags, such as delayed symptom onset and response to prednisone, is crucial for accurate diagnosis and management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/med-2024-1033","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:39:02Z","timestamp":1725439142000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy"],"prefix":"10.1515","volume":"19","author":[{"given":"Andreas Albert","family":"Braun","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital Zurich , Zurich , Switzerland"},{"name":"Faculty of Medicine, University of Zurich , Zurich , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Atiya","sequence":"additional","affiliation":[{"name":"Practice \u201cNeurologie M\u00e4nnedorf\u201d , M\u00e4nnedorf , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"G\u00f6hner","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Hortobagyi","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, University Hospital Zurich , Zurich , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Burkhardt","sequence":"additional","affiliation":[{"name":"Practice \u201cDr. Tobias Burkhardt\u201d , M\u00e4nnedorf , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Schreiner","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Zurich , Zurich , Switzerland"},{"name":"Faculty of Medicine, University of Zurich , Zurich , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"2024090408364088241_j_med-2024-1033_ref_001","doi-asserted-by":"crossref","unstructured":"Leverenz D, Zaha O, Crofford LJ, Chung CP. Causes of creatine kinase levels greater than 1,000 IU\/L in patients referred to rheumatology. Clin Rheumatol. 2016 Jun;35(6):1541\u20137.","DOI":"10.1007\/s10067-016-3242-9"},{"key":"2024090408364088241_j_med-2024-1033_ref_002","unstructured":"Preston MK, Tawil R, Wang LH Facioscapulohumeral muscular dystrophy. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al. editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1443\/."},{"key":"2024090408364088241_j_med-2024-1033_ref_003","doi-asserted-by":"crossref","unstructured":"Hamann PDH, Cooper RG, McHugh NJ, Chinoy H. Statin-induced necrotizing myositis \u2013 a discrete autoimmune entity within the \u201cstatin-induced myopathy spectrum. Autoimmun Rev. 2013 Oct;12(12):1177\u201381.","DOI":"10.1016\/j.autrev.2013.07.001"},{"key":"2024090408364088241_j_med-2024-1033_ref_004","doi-asserted-by":"crossref","unstructured":"Khoo T, Chinoy H. Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues. Autoimmun Rev. 2023 Dec;22(12):103468.","DOI":"10.1016\/j.autrev.2023.103468"},{"key":"2024090408364088241_j_med-2024-1033_ref_005","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020 Dec;16(12):689\u2013701.","DOI":"10.1038\/s41584-020-00515-9"},{"key":"2024090408364088241_j_med-2024-1033_ref_006","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, et al. Necrosis in anti-SRP + and anti-HMGCR + myopathies. Neurology. 2018 Feb;90(6):e507\u201317.","DOI":"10.1212\/WNL.0000000000004923"},{"key":"2024090408364088241_j_med-2024-1033_ref_007","doi-asserted-by":"crossref","unstructured":"Alshehri A, Choksi R, Bucelli R, Pestronk A. Myopathy with anti-HMGCR antibodies. Neurol Neuroimmunol Neuroinflammation. 2015 Jun;2(4):e124.","DOI":"10.1212\/NXI.0000000000000124"},{"key":"2024090408364088241_j_med-2024-1033_ref_008","doi-asserted-by":"crossref","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018 Mar;20(4):21.","DOI":"10.1007\/s11926-018-0732-6"},{"key":"2024090408364088241_j_med-2024-1033_ref_009","doi-asserted-by":"crossref","unstructured":"Paganoni S, Amato A. Electrodiagnostic evaluation of myopathies. Phys Med Rehabil Clin North Am. 2013 Feb;24(1):193\u2013207.","DOI":"10.1016\/j.pmr.2012.08.017"},{"key":"2024090408364088241_j_med-2024-1033_ref_010","doi-asserted-by":"crossref","unstructured":"Heatwole CR, Statland JM, Logigian EL. The diagnosis and treatment of myotonic disorders. Muscle Nerve. 2013 May;47(5):632\u201348.","DOI":"10.1002\/mus.23683"},{"key":"2024090408364088241_j_med-2024-1033_ref_011","doi-asserted-by":"crossref","unstructured":"Tihaya MS, Mul K, Balog J, de Greef JC, Tapscott SJ, Tawil R, et al. Facioscapulohumeral muscular dystrophy: the road to targeted therapies. Nat Rev Neurol. 2023 Feb;19(2):91\u2013108.","DOI":"10.1038\/s41582-022-00762-2"},{"key":"2024090408364088241_j_med-2024-1033_ref_012","doi-asserted-by":"crossref","unstructured":"Munekane A, Ohsawa Y, Okubo M, Nagai T, Nishimura H, Nishino I, et al. Becker muscular dystrophy accompanied by anti-HMGCR antibody-positive immune-mediated necrotizing myopathy. Intern Med. 2023 May;62(9):1345\u20139.","DOI":"10.2169\/internalmedicine.0202-22"},{"key":"2024090408364088241_j_med-2024-1033_ref_013","doi-asserted-by":"crossref","unstructured":"Rijken NHM, van der Kooi EL, Hendriks JCM, van Asseldonk RJGP, Padberg GW, Geurts ACH, et al. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement. Neuromuscul Disord. 2014 Dec;24(12):1087\u201396.","DOI":"10.1016\/j.nmd.2014.05.012"},{"key":"2024090408364088241_j_med-2024-1033_ref_014","doi-asserted-by":"crossref","unstructured":"Rademacher JG, Glaubitz S, Zechel S, Oettler M, Tampe B, Schmidt J, et al. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data. Clin Exp Rheumatol. 2022 Feb;40(2):320\u20138.","DOI":"10.55563\/clinexprheumatol\/2ao5ze"},{"key":"2024090408364088241_j_med-2024-1033_ref_015","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Allenbach Y, Amato A, et al. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord. 2018 Jan;28(1):87\u201399.","DOI":"10.1016\/j.nmd.2017.09.016"},{"key":"2024090408364088241_j_med-2024-1033_ref_016","doi-asserted-by":"crossref","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primer. 2021 Dec;7(1):87.","DOI":"10.1038\/s41572-021-00321-x"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2024-1033\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2024-1033\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:39:12Z","timestamp":1725439152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2024-1033\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,4]]},"published-print":{"date-parts":[[2024,9,4]]}},"alternative-id":["10.1515\/med-2024-1033"],"URL":"https:\/\/doi.org\/10.1515\/med-2024-1033","relation":{},"ISSN":["2391-5463"],"issn-type":[{"type":"electronic","value":"2391-5463"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"20241033"}}